This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

27 Oct 2011

Teva and Dr Reddy's Launch Generic Zyprexa

Teva and Dr. Reddy’s Laboratories have launched their generic version of Eli Lilly antipsychotic Zyprexa.

Generic drug makers Teva Pharmaceutical Industries and Dr Reddy's Laboratories have announced the commercial launch of olanzapine tablets, a generic version of Eli Lilly antipsychotic Zyprexa. Annual sales of Zyprexa in the US stood at approximately $3.2bn as of September 2011.


Teva will introduce tablets in 2.5mg, 5mg, 7.5mg, 10mg, 15mg doses, while Dr Reddy's will introduce a 20mg tablet. Dr Reddy's is supplying the 20mg version of the product as part of a commercialisation, manufacture and supply agreement agreed in April 2011.


Both companies have been granted a 180-day period of marketing exclusivity in the US for their respective tablets.



Related News